In ATCvet, this subgroup is named "QD05 ''Drugs for keratoseborrheic disorders''".

D05A Antipsoriatics for topical use

::''In ATCvet, this subgroup is named "QD05A Drugs for keratoseborrheic disorders, topical use".''

D05AA
Tar Tar is a dark brown or black viscosity, viscous liquid of hydrocarbons and free carbon, obtained from a wide variety of organic matter, organic materials through destructive distillation. Tar can be produced from coal, wood, petroleum, or peat. ...
s

D05AC Antracen derivatives

:D05AC01 Dithranol :D05AC51 Dithranol, combinations

D05AD
Psoralen Psoralen (also called psoralene) is the parent compound in a family of naturally occurring organic compounds known as the linear furanocoumarins. It is structurally related to coumarin by the addition of a fused furan ring, and may be considered ...
s for topical use

:D05AD01

Trioxysalen Trioxsalen (trimethylpsoralen (TMP), trioxysalen ( INN) or Trisoralen) is a furanocoumarin and a psoralen derivative. It is obtained from several plants, mainly '' Psoralea corylifolia''. Like other psoralens it causes photosensitization of th ...

:D05AD02

Methoxsalen Methoxsalen, sold under the brand name Oxsoralen among others, is a medication used to treat psoriasis, eczema, vitiligo, and some cutaneous lymphomas in conjunction with exposing the skin to ultraviolet (UVA) light from lamps or sunlight. Methox ...

D05AX Other antipsoriatics for topical use

::''In ATCvet, this subgroup is named "QD05AX Other drugs for keratoseborrheic disorders for topical use".'' :D05AX01

Fumaric acid Fumaric acid is an organic compound with the formula HO2CCH=CHCO2H. A white solid, fumaric acid occurs widely in nature. It has a fruit-like taste and has been used as a food additive. Its E number is E297. The salts and esters are known as fum ...

:D05AX02

Calcipotriol Calcipotriol, also known as calcipotriene, is a synthetic derivative of calcitriol, a form of vitamin D. It is used in the treatment of psoriasis. It is safe for long-term application in psoriatic skin conditions. It was patented in 1985 and a ...

:D05AX03

Calcitriol Calcitriol is the active form of vitamin D, normally made in the kidney. It is also known as 1,25-dihydroxycholecalciferol. It is a hormone which binds to and activates the vitamin D receptor in the nucleus of the cell, which then increases the ...

:D05AX04 Tacalcitol :D05AX05

Tazarotene Tazarotene, sold under the brand name Tazorac, among others, is a third-generation prescription topical retinoid. It is primarily used for the treatment of plaque psoriasis and acne. Tazarotene is also used as a therapeutic for photoaged and p ...

:D05AX52 Calcipotriol, combinations :D05AX55 Tazarotene and ulobetasol

D05B Antipsoriatics for systemic use

::''In ATCvet, this subgroup is named "QD05B Drugs for keratoseborrheic disorders, systemic use".''

D05BA Psoralens for systemic use

:D05BA01

:D05BA02

:D05BA03 Bergapten

D05BB
Retinoid The retinoids are a class of chemical compounds that are vitamers of vitamin A or are chemically related to it. Retinoids have found use in medicine where they regulate epithelial cell growth. Retinoids have many important functions throughout ...
s for treatment of
psoriasis Psoriasis is a long-lasting, noncontagious autoimmune disease characterized by raised areas of abnormal skin. These areas are red, pink, or purple, dry, itchy, and scaly. Psoriasis varies in severity from small, localized patches to complet ...

:D05BB01

Etretinate Etretinate (trade name Tegison) is a medication developed by Hoffmann–La Roche that was approved by the FDA in 1986 to treat severe psoriasis. It is a second-generation retinoid. It was subsequently removed from the Canadian market in 1996 and ...

:D05BB02

Acitretin Acitretin (trade names Soriatane and Neotigason) is a second-generation retinoid. It is taken orally, and is typically used for psoriasis. Acitretin is an oral retinoid used in the treatment of severe resistant psoriasis. Because of the potenti ...

D05BX Other antipsoriatics for systemic use

::''In ATCvet, this subgroup is named "QD05BX Other drugs for keratoseborrheic disorders for systemic use".'' :D05BX51

derivatives, combinations

References

{{Antipsoriatics D05